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GC–MSAbstract The aims of this study were to examine the chemical composition of the essential oil of
Premna integrifolia Linn (Lamiaceae), and to test the efﬁcacy of the oil and various organic extracts
as an antibacterial potential. The chemical compositions of the essential oil were analyzed byGC–MS.
Twenty-nine compounds representing 94.81% of the total leaves oil were identiﬁed, of which phytol
(27.25%), a-humulene (14.21%), spathulenol (12.12%), 1-octen-3-ol (8.21%), eugenol (6.69%) and
phenylethyl alcohol (5.81%) were the major compounds. The oil (15 lL disk1) and extracts
(300 lg disk1) of P. integrifolia displayed a great potential of antibacterial activity against Sarcina
lutea IFO 3232, Bacillus subtilis IFO 3026, Escherichia coli IFO 3007, Pseudomonas sp. ATCC
13867,Klebsiella pneumoniaeATCC10031 andXanthomonas campestries IAM1671with their respec-
tive zones of inhibition of 12.0 ± 1.2 to 22.1 ± 1.2 mm and MIC values of 62.5–250 lg mL1. The
results of this study suggest that the natural products derived from P. integrifoliamay have potential
use in food, pharmaceutical and/or agro industries for preservatives or antimicrobial agents.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Many pathogenic microorganisms such as Sarcina lutea,
Bacillus subtilis,Escherichia coli, Klebsiella pneumoniae, Pseudo-monas sp. and Xanthomonas campestries have been reported as
the causal agents of some diseases in human and plants
(McCabe-Sellers and Samuel, 2004). A variety of different
chemical and synthetic compounds have been used as antimicro-
bial agents to inhibit pathogenic bacteria. The demands for
more natural antimicrobials have driven scientists to investigate
the effectiveness of inhibitory compounds such as essential oils,
and extracts from plants (Demirci et al., 2008; Rahman and
Kang, 2009). Essential oils are a complex mixture of
compounds, mainly monoterpenes, sesquiterpenes, and their
corresponding oxygenated derivatives (alcohols, aldehydes, es-
ters, ethers, ketones, phenols, and oxides) from plants, which
are widely known for their scents and ﬂavors. Plant-derived
essential oils have been long used as ﬂavoring agents or preser-
S476 A. Rahman et al.vatives and confectionary products and also have a broad spec-
trum of in vitro antimicrobial activities (Conner, 1993). Thus
essential oils and plant extracts are promising natural antimicro-
bial agents with potential applications in food, pharmaceutical
and/or agro industries for controlling of various pathogens
and spoiling bacteria.
The pharmaceutical and therapeutic potentials of essential
oils and their individual constituents have been evaluated.
The essential oil can be used alone, or as a part of therapeutic
pharmaceutical composition, which includes at least one anti-
microbial compound and a pharmaceutically acceptable
carrier. The essential oils and their volatile constituents can
be used via inhalation or massage therapy. In the ﬁeld of com-
plementary and alternative respiratory medicine, inhalation of
peppermint essential oil vapors has been suggested as an ad-
junct in combined multi-drug therapy in patients with dissem-
inated and inﬁltrative pulmonary tuberculosis (Shkurupii
et al., 2002). Massage therapy using essential oil can be useful
in the treatment for people suffering from dementia (Ballard
et al., 2002). Inﬂammatory diseases, such as allergy, rheuma-
tism and arthritis are often alleviated using essential oil mas-
sage therapy (Maruyama et al., 2005). The use of essential
oils may improve food safety and protect our body against
bacteria causing food poisoning. If essential oils were to be
more widely applied as antibacterials in foods, the organolep-
tic impact would be important. In addition, it is recommended
to apply essential oils or their compounds as part of a hurdle
system and to use it as an antimicrobial component along with
other preservation techniques, e.g. in combination with
reduced temperature and reduced pH or using a synergistic
combination of essential oils and their compounds (Ultee
et al., 2000).
Premna integrifolia Linn. (Lamiaceae) is a garden shrub, 40
species of this genus are widely naturalized in tropical and sub-
tropical regions throughout the world, including Australia,
China and the United States, India and Bangladesh. In
Bangladesh, it is found mostly in Chittagong and Sunderbans.
It is also been seen cultivated in home yards and gardens. In
the ayurvedic system of medicine, P. integrifolia is known as
Ganikarica while its conventional name is Ganiari. There are
many species belonging with this genus but only two species
namely P. latifolia and P. integrifolia were recorded as medic-
inal species. P. latifolia is grown as a large tree but P. integri-
folia is comparatively smaller known as shrub i.e., a woody
plant smaller than a tree with branches lower than the ground
and it is generally grown to 5–6 m tall. Normally most species
of Premna especially P. integrifolia is used for the remedies of
different ailments as in the traditional system in the indigenous
part of the country. The plant is very effective in reducing
blood cholesterol (Dey, 2006). If 12–18 g of leaf and bark is
mixed with four cups of water and after boiling a person suf-
fering from Jaundice drinks it, the Jaundice will be reduced
and he will come round. It is also used for the correction of
menstrual problems. It is very effective for the treatment of
kidney disease, liver problems and constipation (Husain
et al., 1992).
Previous reports showed that the root of P. integrifolia
contained some bioactive compounds such as alkaloids, ﬂavo-
noids, glycosides, tannins, phenolic compounds and diterpe-
noids (Mali and Bhadane, 2010; Yadav et al., 2010, 2011). In
this study, we examined the chemical composition of the essen-
tial oil from leaves of P. integrifolia by GC–MS, and tested theantibacterial efﬁcacy of the essential oil and various organic
extracts with emphasis for the possible future use of the ex-
tracts as an alternative to chemical bactericides.2. Materials and methods
2.1. Plant materials
The leaves of P. integrifolia were collected from the Boro
Parulia, Gopalgonj; Arappur, Jhenaidah and Ambaria,
Kushtia of Bangladesh, in January 2009 and identiﬁed by
Dr. Oliur Rahman, Bangladesh National Herbarium,
Dhaka, where a voucher specimen (DACB 35170) has been
deposited.
2.2. Isolation of the essential oil
The air-dried leaves (200 g) of P. integrifolia were subjected to
hydro distillation for 3 h using a Clevenger type apparatus.
The oil was dried over anhydrous Na2SO4 and preserved in
a sealed vial at 4 C for further analysis.2.3. Preparation of organic extracts
The air-dried leaves P. integrifolia were ﬁrst pulverized into
powdered form. The dried powder (50 g) was then extracted
with hexane, chloroform, ethyl acetate and methanol sepa-
rately at room temperature for 7 days and the solvents were
evaporated by vacuum rotary evaporator temperature at
50 C. The extraction process yielded hexane (7.3 g), chloro-
form (6.2 g), ethyl acetate (7.4 g) and methanol (6.5 g) extracts
respectively. Solvents (analytical grade) for extraction were ob-
tained from commercial sources (Sigma Aldrich, St. Louis,
MO, USA).2.4. Gas chromatography–mass spectrometry (GC–MS)
analysis
The GC–MS was carried out using total ion monitoring mode
on a Varian 3800 gas chromatograph interfaced to a Varian
Saturn ion trap 2200 GC–MS spectrometer. The temperatures
of transfer line and ion source were 280 C and 275C respec-
tively. Ions were obtained by electron ionization mode. The
VF-5 capillary column (30 m length, 0.25 mm I.D. and
0.25 lm ﬁlm thickness) was used. A 20% split injection mode
was selected with a solvent delay time of 3 min with injection
volume 0.2 lL. The initial column temperature was started at
50 C for 1 min, programed at 8 C min1 to 200 C and heated
until 280 C at 10 C min1. Injection port was set at 250 C.
Helium was used as the carrier gas at a constant ﬂow rate of
1.0 mL min1. Molecular ions (mass range: 40–500 m z1) were
monitored for identiﬁcation. The relative percentage of the oil
constituents was expressed as percentage by peak area
normalization.
Identiﬁcation of components of the essential oil was based
on their retention indices, relative to a homologous series of
n-alkane (C8–C20) on the VF-5 capillary column under the
same operating conditions and computer matching with the
GC–MS spectra from the Wiley 6.0 MS data and literature
data (Adams, 2001).
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The following microorganisms were used in the antibacterial
test: Sarcina lutea IFO 3232, Bacillus subtilis IFO 3026,
Escherichia coli IFO 3007, Pseudomonas sp. ATCC 13867,
Klebsiella pneumoniaeATCC 10031 and Xanthomonas campest-
ries IAM 1671. The strains were kindly provided by Prof. Yong
Se Lee, Department of Bioresource Technology, College of
Agriculture and Environmental Science, Daegu University,
Korea. Cultures of each bacterial strain were maintained on
Luria-Bertani (LB) agar medium at 4 C.Table 1 Chemical composition of the essential oil of Premna
integrifolia Linn.
RIa Compound Composition (%)
719 Cyclohexane 1.03
856 Hexan-1-ol 0.65
932 a-Pinene 0.862.6. Determination of antibacterial activity of essential oil and
organic extracts
The dried extracts were dissolved in the same solvent used for
their extraction and sterilized by ﬁltration using 0.22 lm sterile
Millipore ﬁlter (Millipore Corp., Billerica, MA, USA). Then
the antibacterial test was carried out by the agar disk diffusion
method (Murray et al., 1999) using 100 lL of standardized
inoculum suspension containing 107 CFU mL1 of bacteria.
The essential oil was diluted 1:5 (v/v) with methanol and ali-
quots of 15 lL were spotted onto the sterile Whatman No. 1
ﬁlter paper disks (6 mm diameter); while 10 lL of 30 mg mL
1 of each organic extract (300 lg disk1) was applied on the
ﬁlter paper disks and placed on the inoculated LB agar. Neg-
ative controls were prepared using the same solvents employed
to dissolve the samples. Standard antibiotic, streptomycin
(20 lg disk1 from Sigma–Aldrich Co., St. Louis, MO, USA)
was used as positive control for the tested bacteria. The plates
were incubated micro aerobically at 37 C for 24 h. Antibacte-
rial activity was evaluated by measuring the diameter of the
zones of inhibition against the tested bacteria. Each assay in
this experiment was replicated three times.961 1-Octen-3-ol 8.21
963 b-Pinene 1.11
966 3-Octanol 0.97
1005 1,8-Cineole 0.93
1028 cis -2-Octenal 1.13
1136 Phenylethyl alcohol 5.81
1174 Indole 0.91
1182 Decanal 0.87
1200 Dodecane 0.49
1366 Damascenone 0.18
1380 Eugenol 6.69
1386 Azulene 0.61
1410 Isoeugenol 1.83
1414 b-Carryophyllene 0.92
1426 Benzofuranone 0.98
1447 a-Humulene 14.21
1550 Spathulenol 12.12
1561 Caryophyllene oxide 2.60
1580 Cubenol 1.67
1609 Tetradecanal 0.32
1616 Tumerone 0.83
1755 Pentadecanol 0.64
1869 Pentadecanoic acid 0.23
1968 Hexadecanoic acid 1.06
2009 Eicosane 0.62
2045 Phytol 27.25
Total 94.81
a Retention index relative to n-alkanes on VF-5 capillary column.2.7. Minimum inhibitory concentration (MIC)
Minimum inhibitory concentrations (MICs) of the samples
were tested by the standard NCCL method (NCCLS, 2008).
Active cultures for MIC determination were prepared by trans-
forming a loopful of cells from stock cultures to ﬂasks and
inoculated in LB medium and incubated at 37 C for 24 h.
The cultures were diluted with fresh LB broth to achieve opti-
cal density of 107 CFU mL1 for the test organisms at 600 nm
by UV/Vis Spectrophotometer Optizen 2120UV and Optizen
III (Shin et al., 2007). Dilutions, to get the ﬁnal concentration
ranging from 0 to 1000 lg mL1 of essential oil and various or-
ganic extracts in Luria-Bertani broth medium were prepared in
96 well microplates. Finally 20 lL inoculum of each bacterial
strain (107 CFU mL1) was inoculated onto the microplates
and the tests were performed in a volume of 200 lL. The plates
were incubated at 37 C for 24 h. The lowest concentrations of
the test samples, which did not show any visual growth of test
organisms after macroscopic evaluation, were determined as
MICs, which were expressed in lg/mL1. The MICs were
measured for the oil and various extracts, as well as for stan-
dards of pure a-humulene, spathuleno and eugenol, which
were tested on the same cultures under identical conditions
to compare their activity with those of the investigated oil
and extracts.2.8. Statistical analysis
The essential oil and different organic extracts were assayed
for antibacterial activity. Each experiment was run in tripli-
cate, and mean values were calculated. The statistical analysis
was carried out employing one way ANOVA (p< 0.05). A
statistical package (SPSS version 11.0) was used for the data
analysis.
3. Results
3.1. Chemical composition of the essential oil
GC–MS analyses of the oil led to the identiﬁcation of 29 differ-
ent compounds, representing 94.81% of the total oil from
leaves. The identiﬁed compounds are listed in Table 1, accord-
ing to their elution order on a VF-5 capillary column. The oil
contains a complex mixture consisting of mainly oxygenated
mono- and sesquiterpenes, and mono- and sesquiterpene
hydrocarbons. The major compounds detected in the leaves
oil were phytol (27.25%), a-humulene (14.21%), spathulenol
(12.12%), 1-octen-3-ol (8.21%), eugenol (6.69%), phenylethyl
alcohol (5.81%) and caryophyllene oxide (2.6%), as shown in
Table 1. Hexadecanoic acid (1.06%), 1,8-cineole (0.93%), a-
pinene (0.86%), b-pinene (1.11%), b-carryophyllene (0.92%)
Table 2 Antibacterial activity of essential leaf oil and various extracts of Premna integrifolia Linn.
Microorganism Zones of inhibition (mm)
Essential oil Various extracts SM
MeOH Hexane CHCl3 EtOAc
Sarcina lutea IFO 3232 22.1 ± 1.2a 20.1 ± 0.5a 14.1 ± 0.7a 18.2 ± 1.1a 20.1 ± 1.2a 20.2 ± 0.5a
Bacillus subtilis IFO 3026 20.2 ± 1.3b 18.2 ± 1.1b 14.2 ± 0.5a 16.1 ± 1.5b 19.3 ± 1.2a 16.1 ± 0.7c
Escherichia coli IFO 3007 15.3 ± 1.2c 15.1 ± 1.0c 12.2 ± 1.1b 13.1 ± 0.5c 15.2 ± 1.1b 17.4 ± 1.2b
Pseudomonas sp. ATCC 13867 14.2 ± 0.7cd 13.1 ± 0.5d 12.2 ± 1.1b 12.1 ± 1.2c 13.1 ± 1.2c 16.2 ± 1.3c
Klebsiella pneumoniae ATCC 10031 13.1 ± 1.5d 13.2 ± 1.1d 12.3 ± 1.2b 12.0 ± 1.2c 13.3 ± 1.6c 17.3 ± 0.6b
Xanthomonas campestries IAM 1671 14.2 ± 0.5cd 14.1 ± 0.5cd 12.1 ± 1.2b 12.1 ± 1.2c 15.2 ± 0.6b 16.3 ± 0.6c
Diameter of inhibition zones of essential oil including diameter of disk 6 mm (tested at a volume of 15 lL disk1).
Various extracts (300 lg disk1).
Standard antibiotic: SM, streptomycin (20 lg disk1).
Values are given as mean ± S.D. (n= 3).
Values in the same column with different superscripts are signiﬁcantly different (p< 0.05).
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nents of P. integrifolia oil in the present study.
3.2. Antibacterial activity of essential oil and organic extracts
The in vitro antibacterial activity of essential oil, various
organic extracts of P. integrifolia against the employed bacte-
ria were qualitatively assessed by the presence or absence of
inhibition zones. The oil exhibited antibacterial activity against
all two Gram-positive and four Gram-negative bacteria at the
concentrations of 15 lL of 1:5 (v/v) dilution with MeOH. The
oil exhibited a potent inhibitory effect against S. lutea IFO
3232, B. subtilis IFO 3026, E. coli IFO 3007, Pseudomonas
sp. ATCC 13867, K. pneumoniae ATCC 10031 and X. campest-
ries IAM 1671 with diameter of inhibition zones ranging from
of 13.1 ± 1.5 to 22.1 ± 1.2 mm, as shown in Table 2. Metha-
nol, chloroform and ethyl acetate extracts of P. integrifolia
also revealed a great potential of antibacterial activity against
all bacteria, at the concentrations of 300 lg disk1 (Table 2).
Methanol and ethyl acetate extracts showed the strongest anti-
bacterial effect against S. lutea IFO 3232, B. subtilis IFO 3026,
E. coli IFO 3007 and X. campestries IAM 1671 (inhibition
zones: 20.1 ± 0.5 to 14.1 ± 0.5 mm). On the other hand, chlo-
roform extract showed moderate to high antibacterial effectsTable 3 MIC of essential oil and various extracts of Premna integr
Microorganism Minimum inhibitory concentrati
Essential oil Extracts
MeOH Hexa
Sarcina lutea IFO 3232 62.5 62.5 250
Bacillus subtilis IFO 3026 62.5 62.5 250
Escherichia coli IFO 3007 125 125 250
Pseudomonas sp. ATCC 13867 250 250 250
Klebsiella pneumoniae ATCC 10031 250 250 250
Xanthomonas campestries IAM 1671 125 125 250
Minimum inhibitory concentration (values in lg mL1).
A pure compound is considered inactive when MIC > 20 lg mL1.
nt: Not tested.against most of the bacteria that have being tested (inhibition
zones: 12.0 ± 1.2 to 18.2 ± 1.1 mm). Hexane fraction dis-
played a moderate inhibitory effect against most of the bacte-
ria. In this study, the oil, methanol and ethyl acetate extracts
exhibited higher or similar types of antibacterial activity than
that of streptomycin against Gram-positive bacteria. The blind
control did not inhibit the growth of the bacteria tested. Meth-
anol and ethyl acetate extracts showed higher activity com-
pared with hexane and chloroform extracts.
3.3. Minimum inhibitory concentration (MIC)
As shown in Table 3, the MIC values for the oil were found
lower for S. lutea IFO 3232, B. subtilis IFO 3026, E. coli
IFO 3007 and X. campestries IAM 1671 (62.5–125 lg mL1)
than for Pseudomonas sp. ATCC 13867 and K. pneumoniae
ATCC 10031 (250 lg mL1). On the other hand, MIC values
of the various organic extracts against the tested bacteria were
found in the range 62.5–250 lg mL1 (Table 3). In this study,
the Gram-positive bacteria were found to be more susceptible
to the essential oil and various solvent extractions than Gram-
negative bacteria. Standard pure compounds such a-humu-
lene, spathulenol and eugenol in this study were also exhibited
potent activity as compared to oil or extracts.ifolia Linn and standard pure compounds.
on (MIC)
Standard pure compounds
ne CHCl3 EtOAc a-Humulene Spathulenol Eugenol
125 125 3.90 15.62 7.81
125 62.5 3.90 15.62 7.81
62.5 62.5 >20 >20 15.62
125 125 nt nt nt
250 125 nt nt nt
250 250 7.81 15.62 7.81
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In this study, the essential oil and various organic extracts of
P. integrifolia exhibited potential activity against some of the
bacterial strains such as S. lutea IFO 3232, B. subtilis IFO
3026, E. coli IFO 3007, Pseudomonas sp. ATCC 13867, K.
pneumoniae ATCC 10031 and X. campestries IAM 1671. This
activity could be attributed to the presence of oxygenated
mono- and sesquiterpene hydrocarbons, and these ﬁndings
are in agreement with the previous reports (Shunying et al.,
2005). In our opinion, major components of the oil, phytol
(27.25%), a-humulene (14.21%), spathulenol (12.12%), 1-oc-
ten-3-ol (8.21%), eugenol (6.69%), phenylethyl alcohol
(5.81%) and caryophyllene oxide (2.6%) have key roles for
their antibacterial activities. Antibacterial activities of these
compounds have been reported by others (Sartoratto et al.,
2004; Inouye et al., 2006; Deba et al., 2008). Pure compounds
such as a-humulene, spathulenol and eugenol showed potent
antibacterial activity in this study. Also, the antibacterial activ-
ity of individual components of essential oils such as a-humu-
lene or spathulenol has been reported previously (Bougatsos
et al., 2004; Pichette et al., 2006). On the other hand, the com-
ponents in lower amount such as hexadecanoic acid, 1,8-cine-
ole, a-pinene, b-pinene and b-carryophyllene also contributed
to antibacterial activity of the oils (Salehi et al., 2007; Deba
et al., 2008). It is also possible that the minor components
might be involved in some type of synergism with the other ac-
tive compounds (Marino et al., 2001). Further, the antibacte-
rial activity of organic extract could be attributed to the
presence of some bioactive phytochemicals (alkaloids, ﬂavo-
noids, steroids, tannins, phenolic compounds, diterpenoids,
etc.) in P. integrifolia plant and these ﬁndings are in agreement
with the previous reports (Gokani et al., 2007; Mali and Bha-
dane, 2010; Yadav et al., 2010, 2011).
In pharmaceutical industries there is a continuing need to
ﬁnd new and improved antimicrobial agents, especially in view
of the increasing incidence of antibiotic resistance. One of the
areas which is subjected to considerable interest is plant ex-
tracts and in particular their essential oils. Also, the increasing
consumer demand for effective and safe natural products
means that quantitative data on plant oils and extracts are re-
quired. Report on the analyses of essential oils from P. integ-
rifolia from South Asian regions and its antimicrobial activity
is still scare. Therefore, screening of the medicinal plant, P.
integrifolia growing in Bangladesh, for antimicrobial activity
and phytochemicals is important for ﬁnding potential new
compounds for medicinal or other uses.
5. Conclusion
The essential oil and organic extracts in our study showed a
great potential of antibacterial activity against S. lutea IFO
3232, B. subtilis IFO 3026, E. coli IFO 3007, Pseudomonas
sp. ATCC 13867, K. pneumoniae ATCC 10031 and X. campest-
ries IAM 1671. This activity could be attributed to the pres-
ence of major components (e.g., a-humulene, spathulenol
and eugenol) and/or minor components present in the oil. Re-
sults of our study suggest the possibility of using the oil or or-
ganic extracts of P. integrifolia as natural antimicrobials in
food or pharmaceutical industry because they possess strong
antibacterial activities. The use of plant extracts and essential
oils in consumer goods is expected to increase in the futuredue to the risk of ‘‘green consumerism’’, which stimulates the
use and development of products derived from plants, as both
consumers and regulatory agencies are more comfortable with
the use of natural antimicrobials. However, further research is
needed in order to establish the real application of P. integrifo-
lia essential oil or extracts in food or pharmaceuticals.
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